SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending as investors react to a high-profile endorsement from Nvidia's CEO, who described the company as a future trillion-dollar entity. While the surge has sparked a massive gamma squeeze and intense retail FOMO, the community is deeply divided between long-term bulls betting on AI connectivity infrastructure and skeptics warning of a speculative bubble detached from current earnings fundamentals.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop stock is surging in after-hours trading following a surprise early release of strong first-quarter results and the approval of a $2 billion share buyback program. The community is actively debating the company's path to profitability and interpreting the buyback as a strategic move to defend the share price against short interest.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

The iShares Semiconductor ETF (SOXX) is currently trending due to its extreme parabolic ascent and unprecedented technical extension above its 200-day moving average, fueling fierce debate over whether the AI-driven rally is a sustainable supercycle or an unsustainable bubble reminiscent of 2000. While bullish investors point to unrelenting institutional demand and AI infrastructure expansion as justification for the move, bears are highlighting extreme overbought signals, potential corporate AI spending fatigue, and rising volatility, leaving the community divided between riding the momentum and bracing for a structural correction.

Shake Shack, Inc. engages in the operation and licensing of Shake Shack restaurants which serve burgers, hot dogs, crinkle cut fries, shakes, frozen custard, beer, wine, and related products. The company was founded by Daniel Harris Meyer on September 23, 2014 and is headquartered in New York, NY.

Shake Shack Inc - Ordinary Shares - Class A

Shake Shack is under significant pressure following a downward revision of its second-quarter guidance, which has triggered analyst price target cuts and fueled intense debate among investors regarding the company's long-term profitability in a high-inflation environment. While some in the community see the recent sell-off as an overreaction that presents a buying opportunity, others remain skeptical, pointing to the CEO's credibility and weakened consumer traffic as signs of fundamental trouble.

The WalletConnect Network is the onchain UX ecosystem. It is the open and decentralized network that enables users to connect to apps across the globe. It continues to power over 15M monthly connections for users across the world's leading decentralized applications and 300+ chains. In the past 12 months, the WalletConnect Network has grown by over 240%. Simply put, the WalletConnect Network plays a critical role in the $2+ trillion that flows throughout web3 today.

WalletConnect Token

WalletConnect Token is drawing significant attention from investors as it experiences heightened volatility, with community members actively discussing its potential for a breakout and debating the impact of centralized exchange listings. Sentiment remains divided, as some traders highlight the token's integration within the broader crypto ecosystem while others remain cautious of frequent price manipulation and whale activity.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is seeing heightened community discussion and volatility as investors pivot toward upcoming AACR presentations and potential interim trial data updates. The community remains focused on the company's progress in breast cancer immunotherapy, viewing the stock's recent price action as a consolidation period ahead of anticipated catalysts that could impact institutional interest.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing a massive surge in volume and price as the community rallies around its pivot to physical AI and automotive software via the QNX platform. Investors are actively discussing a potential short squeeze and viewing the recent momentum as a fundamental re-rating of the companys growth prospects.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is currently trending as investors focus on massive AI infrastructure contracts and a shifting sentiment, as the community debates potential short squeezes versus concerns over future capital requirements. Sentiment is fueled by high-profile deal announcements with major partners, leading to significant volatility and intense discussion regarding the stock's long-term valuation relative to its rapidly expanding project pipeline.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is facing heightened market pressure as it struggles to maintain key support levels, with investors heavily debating whether the current price represents a long-term accumulation opportunity or a sign of deeper structural decline. The community remains deeply divided, with many expressing frustration over the coin's lagging performance compared to Bitcoin, while others look toward the institutional potential of real-world asset tokenization and the Clarity Act as long-term catalysts for a potential reversal.

Exxon Mobil Corp. engages in the exploration, development, and distribution of oil, gas, and petroleum products. It operates through the following segments: Upstream, Energy Products, Chemical Products, and Specialty Products. The Upstream segment organizes the exploration of crude oil and natural gas. The Energy Products segment includes fuels, aromatics, and catalyst and licensing. The Chemical Products segment offers petrochemicals. The Specialty Products segment provides finished lubricants, basestocks and waxes, synthetics, and elastomers and resins. The company was founded by John D. Rockefeller in 1882 and is headquartered in Spring, TX.

Exxon Mobil Corp.

Exxon Mobil Corp

Exxon Mobil is seeing high community engagement as traders react to persistent instability in the Strait of Hormuz and conflicting reports surrounding Middle East ceasefire negotiations. Investors are weighing the impact of continued geopolitical risk and tight global oil supplies against the stock's recent price volatility and upcoming quarterly earnings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BioMarin Pharmaceutical Inc. (BMRN) A Stock that Could 10x by 2030 on Pipeline Development

BioMarin Pharmaceutical Inc. (BMRN) A Stock that Could 10x by 2030 on Pipeline Development...

BioMarin's Voxzogo Meets Goal in Late-Stage Study for Hypochondroplasia

BMRN's shares rise after Voxzogo hits the main goal in a late-stage hypochondroplasia study, supporting planned FDA filings in 2026.

BioMarin Announces Positive Phase 3 Pivotal Study Results for VOXZOGO (vosoritide) in Children with Hypochondroplasia

BioMarin Announces Positive Phase 3 Pivotal Study Results for VOXZOGO (vosoritide) in Children with Hypochondroplasia BioMarin Announces Positive Phase 3 Pivotal Study Results for VOXZOGO (vosoritide) in Children with Hypochondroplasia PR Newswire SAN RAFAEL, Calif., May 20, 2026 Study met primary...

BMRN Stock Down on Mixed Results From Rare Disease Therapy Study 

BioMarin shares fall after BMN 401 meets a biomarker goal but misses a key radiographic endpoint in a late-stage ENPP1 deficiency study.

BioMarin Pharmaceutical Enters Oversold Territory (BMRN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me...

BioMarin Provides Update on Phase 3 Trial for BMN 401 in Children Aged 1-12 With ENPP1 Deficiency

BioMarin Provides Update on Phase 3 Trial for BMN 401 in Children Aged 1-12 With ENPP1 Deficiency BioMarin Provides Update on Phase 3 Trial for BMN 401 in Children Aged 1-12 With ENPP1 Deficiency PR...

Here Are Monday's Top Wall Street Analyst Research Calls: Dell Technologies, BioMarin Pharmaceutical, Disney, HubSpot, Klarna, Oklo, Pitney Bowes, Trade Desk, Wendy's, and More

Here Are Monday's Top Wall Street Analyst Research Calls: Dell Technologies, BioMarin Pharmaceutical, Disney, HubSpot, Klarna, Oklo, Pitney Bowes, Trade Desk, Wendy's, and More...

Sanford C. Bernstein Cuts BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target to $82.00

Sanford C. Bernstein reduced their target price on shares of BioMarin Pharmaceutical from $94.00 to $82.00 and set an "outperform" rating for the company in a report on Tuesday...

BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised

BMRN misses Q1 EPS estimates despite a revenue beat, as charges and higher costs weigh on profits, while new Amicus deal lifts the 2026 outlook.

BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Lowered to $119.00 at Morgan Stanley

Morgan Stanley lowered their price target on shares of BioMarin Pharmaceutical from $120.00 to $119.00 and set an 'overweight' rating on the stock in a report on Tuesday...

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.

BMRNBiomarin Pharmaceutical Inc. - Registered Shares

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BMRN News